Clinical Trials Logo

Clinical Trial Summary

This research seeks to compare two types of vascular access (catheters that are inserted into the vein) for patient treatment during hospitalization. This research will evaluate how long each catheter lasts before presenting problems that may lead to its removal from the vein (the most common are swelling on the site of the catheter, clogging of the catheter, infections, or other less common problems. Each patient will be randomly selected to receive either catheter. In this study, we will also estimate how much each patient will spend if any of the problems mentioned occur.


Clinical Trial Description

This randomized, parallel, open, controlled, single-center clinical trial is blind to outcome analysis. The use of midline catheter will be compared, regarding duration of use without complications, to the use of long peripheral intravenous catheter during continuous our intermittent intravenous therapy in adult clinical patients who have been hospitalized for up to 30 days. The intervention group will consist of hospitalized adult clinical patients who were identified with difficult intravenous access (DIVA) and who received medical indication of continuous or intermittent intravenous therapy for more than five and a maximum of 30 days of treatment. These patients will receive PowerGlide ProTM Midline catheter. The control group will consist of patients with the same profile described as the intervention group and will receive the insertion of a long peripheral venous catheter Introcan Safety Deep Access. At the end of the study, an economic analysis will be carried out from the perspective of the public health system if the intervention group shows favorable results. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05884294
Study type Interventional
Source Hospital de Clinicas de Porto Alegre
Contact Eneida R Rabelo da Silva, ScD
Phone 55 51 33598084
Email esilva@hcpa.edu.br
Status Recruiting
Phase N/A
Start date January 2, 2024
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT06290284 - Comparison Between Mini-midline and the Peripheral Intravenous Catheter N/A
Recruiting NCT02556541 - Ultrasound-guided Peripheral Vascular Access in Children N/A
Completed NCT01958164 - Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device Occlusion Phase 3
Completed NCT04086693 - Peripheral Intravenous Catheter Securement With Tissue Adhesive N/A
Recruiting NCT04692753 - Effect of Education of Health Care Workers on the Maintenance of Venous Access Devices
Completed NCT05378568 - Implementation and Evaluation of the Selection Scheme of Peripheral Venous Infusion Devices for Hospitalized Children N/A
Completed NCT02770560 - Efficacy of Urokinase Containing Locking Solutions for Thrombotic Dysfunction of Tunneled Hemodialysis Catheters N/A
Completed NCT03996733 - Using A Gelatin-Based Model In USG-Guided Jugular Venous Catheter Placement Training N/A
Completed NCT03502980 - Safety and Efficacy of Midline and PICC N/A
Completed NCT06355466 - Tunneled Hemodialysis Catheters as Permanent Vascular Access: Evaluating One-year Patency Rate and Affecting Factors